ZYLOX-TONBRDG.MED.TECH.H1 (818) — Cash Flow Reinvestment Rate
ZYLOX-TONBRDG.MED.TECH.H1 (818) has a Cash Flow Reinvestment Rate of 4.64x as of December 2024, reinvesting €808.05 Million (capex €191.34 Million plus investments €-616.71 Million) from operating cash flow of €174.08 Million. Explore ZYLOX-TONBRDG.MED.TECH.H1 (818) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ZYLOX-TONBRDG.MED.TECH.H1 Cash Flow Reinvestment Rate (2023–2024)
Historical reinvestment intensity for ZYLOX-TONBRDG.MED.TECH.H1 across 2 annual periods. Also explore ZYLOX-TONBRDG.MED.TECH.H1 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for ZYLOX-TONBRDG.MED.TECH.H1 (2023–2024)
Year-by-year capital reinvestment analysis for ZYLOX-TONBRDG.MED.TECH.H1. For live market cap and broader valuation context, see how much is ZYLOX-TONBRDG.MED.TECH.H1 worth.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.64x | €808.05 Million | €174.08 Million | €191.34 Million | ▲ +112.2% |
| 2023 | 2.19x | €215.31 Million | €98.44 Million | €190.92 Million | — |